Q2 2024 · 13F-HR
First Light Asset Management, LLCholdings as filed
Filed 2024-08-14 · accession 0001999371-24-010170
$1.14B
Reported value
44
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 69913P105 | FNAUSD | PARAGON 28 INC | $55.9M | 4.90% | 8,174,832 | Common | SOLE |
| 02081G201 | ATEC | ALPHATEC HOLDINGS INC | $55.7M | 4.88% | 5,327,978 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS INC | $53.8M | 4.71% | 1,200,508 | Common | SOLE |
| 64049M209 | NEO | NEOGENOMICS INC | $52.5M | 4.60% | 3,782,561 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS | $50.9M | 4.46% | 1,306,260 | Common | SOLE |
| 89377M109 | TMDX | TRANSMEDICS GROUP INC | $45.3M | 3.97% | 300,600 | Common | SOLE |
| 04963C209 | ATRC | ATRICURE INC | $44.7M | 3.92% | 1,964,703 | Common | SOLE |
| 45784P101 | PODD | INSULET CORP | $43.5M | 3.81% | 215,637 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS LIMITED | $43.2M | 3.78% | 4,780,560 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $40.0M | 3.50% | 369,068 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL INC | $39.6M | 3.47% | 963,146 | Common | SOLE |
| G5509L101 | LIVN | LIVANOVA PLC | $38.9M | 3.41% | 710,390 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $36.9M | 3.24% | 551,303 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $36.6M | 3.21% | 3,401,213 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $36.4M | 3.19% | 1,005,723 | Common | SOLE |
| 825704109 | SIBN | SI-BONE INC | $32.0M | 2.80% | 2,473,289 | Common | SOLE |
| 77634L105 | RCM1USD | R1 RCM INC | $31.0M | 2.71% | 2,464,809 | Common | SOLE |
| 71377E105 | PFMTUSD | PERFORMANT FINANCIAL CORPORATION | $30.5M | 2.67% | 10,514,200 | Common | SOLE |
| 687793109 | OSCR | OSCAR HEALTH INC CLASS A | $29.5M | 2.59% | 1,865,922 | Common | SOLE |
| 875372203 | TNDM | TANDEM DIABETES CARE INC | $28.5M | 2.50% | 708,482 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $28.0M | 2.46% | 1,384,768 | Common | SOLE |
| 30050B101 | EVH | EVOLENT HEALTH INC | $27.6M | 2.42% | 1,445,305 | Common | SOLE |
| 42225T107 | HCAT | HEALTH CATALYST INC | $25.3M | 2.22% | 3,956,089 | Common | SOLE |
| 05463X106 | AXGN | AXOGEN INC | $24.2M | 2.12% | 3,344,033 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $23.2M | 2.03% | 590,647 | Common | SOLE |
| 45332Y109 | NARIUSD | INARI MEDICAL INC. | $22.7M | 1.99% | 472,384 | Common | SOLE |
| 032724106 | ANAB | ANAPTYS BIO INC | $19.5M | 1.71% | 779,158 | Common | SOLE |
| 68401U204 | OPRX | OPTIMIZERX CORP | $18.3M | 1.60% | 1,826,961 | Common | SOLE |
| 87357P100 | TCMD | TACTILE SYSTEMS TECHNOLOGY INC | $16.0M | 1.40% | 1,338,902 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $13.5M | 1.18% | 382,433 | Common | SOLE |
| 759910102 | KRMD | KORU MEDICAL SYSTEMS INC | $13.4M | 1.17% | 5,038,387 | Common | SOLE |
| 05352A100 | AVTR | AVANTOR INC | $12.6M | 1.11% | 596,124 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH | $12.0M | 1.06% | 416,967 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $10.6M | 0.92% | 139,729 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $8.1M | 0.71% | 2,002,219 | Common | SOLE |
| 70975L107 | PEN | PENUMBRA INC. | $7.8M | 0.68% | 43,108 | Common | SOLE |
| 444859102 | HUM | HUMANA INC | $6.0M | 0.53% | 16,139 | Common | SOLE |
| 15135B101 | CNC | CENTENE CORPORATION | $5.9M | 0.52% | 88,827 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $5.3M | 0.46% | 125,386 | Common | SOLE |
| T9224W109 | STVN | STEVANATO GROUP SPA | $5.0M | 0.44% | 272,833 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $4.9M | 0.43% | 36,157 | Common | SOLE |
| 457730109 | INSP | INSPIRE MEDICAL SYSTEMS INC | $3.8M | 0.33% | 28,135 | Common | SOLE |
| 829214105 | SLP | SIMULATIONS PLUS INC | $1.4M | 0.12% | 28,259 | Common | SOLE |
| 835431107 | — | SONENDO INC | $349,766 | 0.03% | 5,143,615 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.